Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polmacoxib in Osteoarthritis
NCT01765296Phase 3Completed
- Sponsor
- Crystal Genomics
- Start
- Mar 2013
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of polmacoxib in osteoarthritis (OA), sponsored by Crystal Genomics. Started Mar 2013; status: completed.
02
Drugs
polmacoxib
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01765296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01765296.